Fusion proteins composed by a genetically modified cholera toxin subunit A1, peptides from the acetylcholine receptor alpha chain and a dimer of the D fragment fromStaphylococcus aureusprotein A

	Fusion proteins composed by a genetically modified cholera toxin subunit A1, peptides from the acetylcholine receptor alpha chain and a dimer of the D fragment fromStaphylococcus aureusprotein A
Trade Name
Orphan Indication	Myasthenia gravis Myasthenia gravis
EU Market Approval	EU
EU Designation Date	2015-05-21 00:00:00
Sponsor	Toleranzia AB

Learn more about:

Myasthenia gravis